A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (1) , 30-34
- https://doi.org/10.1016/s0165-6147(96)01017-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Safety of Meloxicam: A Global Analysis of Clinical TrialsRheumatology, 1996
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflammation Research, 1995
- Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitorsInflammation Research, 1995
- Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human MacrophagesBiochemical and Biophysical Research Communications, 1995
- Nonsteroidal antiinflammatory drugs and the gastrointestinal tract the double-edged swordArthritis & Rheumatism, 1995
- Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.Journal of Clinical Investigation, 1994
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993
- Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase.Journal of Clinical Investigation, 1985
- Indomethacin increases plasma lithium.BMJ, 1979